Lycopene and prostate cancer: emerging evidence

Michelle L Fraser1, Andy H Lee, Colin W Binns

  • 1Curtin University of Technology, School of Public Health, GPO Box U 1987, Perth WA 6845, Australia. nugget008@hotmail.com

Insights

Lycopene, found in tomatoes, shows promise in preventing prostate cancer. Emerging research from observational, clinical, and animal studies supports its protective role against this common cancer in men.

Area of Science:

  • Oncology
  • Nutritional Science
  • Carotenoid Research

Background:

  • Prostate cancer is a leading cancer in men globally.
  • Tomato consumption is linked to reduced prostate cancer risk.
  • Lycopene, a key tomato carotenoid, is implicated in this protective effect.

Purpose of the Study:

  • To review emerging evidence on lycopene's role in prostate cancer prevention.
  • To synthesize findings from epidemiologic, clinical, and animal studies.
  • To explore the biological mechanisms underlying lycopene's effects.

Main Methods:

  • Review of epidemiologic studies on lycopene and prostate cancer.
  • Analysis of human clinical trials investigating lycopene.
  • Examination of animal studies and biological mechanism research.

Main Results:

  • Observational studies suggest a protective association between lycopene intake and prostate cancer.
  • Recent human and animal studies provide further supporting evidence.
  • Biological mechanisms for lycopene's action in prostate cancer prevention are being elucidated.

Conclusions:

  • Lycopene from tomato products is a promising agent for prostate cancer prevention.
  • Converging evidence from multiple study types supports lycopene's role.
  • Further research into mechanisms can optimize its preventive potential.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...